JAMA+ Women’s Health: September 8, 2026

Trouble viewing this email? Read it Online

This week's JAMA+ Women's Health has an audio episode that discusses ovarian cancer prevention with opportunistic fallopian tube removal. An Original Investigation in JAMA Cardiology examines intersectional inequities in age-related risk of adverse maternal cardiometabolic health. A Review in JAMA Oncology examines systemic therapy considerations in older adults with early-stage breast cancer. Two Original Investigations in JAMA Network Open look at age at menopause and brain atrophy in older women, and at geographic access to crisis pregnancy centers and abortion facilities by state abortion policy.

Explore the latest curated research, commentary, and multimedia from JAMA+ Women's Health in the featured articles below.

Editor's Picks in this week's JAMA+ Women's Health:

• This Medical News feature explores whether phage therapy could become the next major approach for urinary tract infections, surveying the emerging science and clinical pipeline for a common condition that disproportionately affects women. (JAMA)
• An Original Investigation evaluates the effectiveness of the RSV bivalent prefusion F protein vaccine administered during pregnancy in protecting infants against RSV-associated illness. (JAMA Pediatrics)